Hikma to present at 41st Annual J.P. Morgan Healthcare Conference

London, 9 January 2023 – Hikma Pharmaceuticals PLC (Hikma) will present this week at the 41st Annual J.P. Morgan Healthcare Conference. Bassam Kanaan, EVP, Corporate Development and M&A and Susan Ringdal, EVP, Strategic Planning and Global Affairs will present virtually and answer questions at 9:45 AM Pacific Standard Time (5:45 PM GMT) on Wednesday 11 January.

Press Release Corporate 9 January 2023

A live webcast of the presentation will be available by following this link, and will remain available for 30 days. A copy of the presentation will be available on the Investors section of Hikma’s website.

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.